Tailoring Value Propositions to Overcome Access Barriers in Cell & Gene Therapies
Time: 1:40 pm
day: Conference Day Two
Details:
Showcase how some Gene Therapies (GTs) are facing significant barriers to successful price and reimbursement
Understand key payer value barriers for GTs and how these vary by type of gene therapy, namely:
- Durability of effect
- Unmet need
- Cost offsets
Discuss evidence generation strategies to mitigate each of these payer barriers and optimize payer value propositions for GTs
